Sign in

CIK 0001042418 · Non-accelerated filer<br>Smaller reporting company

Inhibitor Therapeutics, Inc.

Sign in to watch
Ticker
INTI
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
541641133
Phone
(813) 766-2462
Business address
4830 W. KENNEDY BLVD., SUITE 600, TAMPA, FL, 33609
Former names
HedgePath Pharmaceuticals, Inc., COMMONWEALTH BIOTECHNOLOGIES INC
  1. 5 Insider Annual Insider Trading Report
  2. 4 Open-market buy Director bought 10,000 shares at $0.13 ($1,300)
  3. 4 Grant or award 10% owner acquired 22,530,227 shares (grant or award)
  4. 4 Other acquisition Executive Chairman acquired 7,232,203 shares (other)
  5. 3 Insider Initial Statement of Ownership
  6. 3 Insider Initial Statement of Ownership
  7. 3 Insider Initial Statement of Ownership
  8. 4 Derivatives Options or other derivatives
  9. 3 Insider Initial Statement of Ownership
  10. 3 Insider Initial Statement of Ownership
  11. 3 Insider Initial Statement of Ownership
  12. 3 Insider Initial Statement of Ownership
  13. 4 Derivatives Options or other derivatives
  14. 3 Insider Initial Statement of Ownership
  15. 4 Derivatives Options or other derivatives
  16. 3 Insider Initial Statement of Ownership
  17. 4 Other acquisition Chief Executive Officer acquired 2,846,715 shares (other)
  18. 4 Other acquisition Director acquired 372,263 shares (other)
  19. 4 Other acquisition Chief Executive Officer acquired 2,025,000 shares (other)
  20. 4 Open-market sale Director sold 19,100 shares at $0.50 ($9,550)

Page 6 of 11 · 219 filings